M2 EQUITYBITES-August 21, 2012-Sanofi Pasteur markets Sklice (ivermectin) Lotion, 0.
Sanofi Pasteur announced on Monday the commercial launch of the prescription Sklice Lotion 0.
M2 PHARMA-August 21, 2012-Sanofi Pasteur markets Sklice
(ivermectin) Lotion, 0.
21 August 2012 - Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN) (NYSE: SNY), said that Sklice (ivermectin) Lotion, 0.
Sklice Lotion was developed to meet the demand for an effective head lice treatment option that is well-tolerated in children 6 months of age and older.
M2 PHARMA-February 8, 2012-Sanofi awarded FDA approval for single treatment option Sklice lotion for head lice for pediatric community(C)2012 M2 COMMUNICATIONS
Healthcare company Sanofi (EURONEXT: SAN) (NYSE:SNY) reported on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) for Sklice Lotion, 0.